These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24601770)

  • 1. Drug discovery studies on quinoline-based derivatives as potential antimalarial agents.
    Sharma R; Patil S; Maurya P
    SAR QSAR Environ Res; 2014; 25(3):189-203. PubMed ID: 24601770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QSAR analysis of thiolactone derivatives using HQSAR, CoMFA and CoMSIA.
    Sainy J; Sharma R
    SAR QSAR Environ Res; 2015; 26(10):873-92. PubMed ID: 26524489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of new potential hits of Plasmodium falciparum enoyl-ACP reductase through ligand- and structure-based drug design approaches.
    Neves BJ; Bueno RV; Braga RC; Andrade CH
    Bioorg Med Chem Lett; 2013 Apr; 23(8):2436-41. PubMed ID: 23499236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum.
    Kumari M; Chandra S; Tiwari N; Subbarao N
    BMC Struct Biol; 2016 Aug; 16():12. PubMed ID: 27534744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D-QSAR studies on triclosan derivatives as Plasmodium falciparum enoyl acyl carrier reductase inhibitors.
    Shah P; Siddiqi MI
    SAR QSAR Environ Res; 2010 Jul; 21(5-6):527-45. PubMed ID: 20818586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CoMFA, CoMSIA, and docking studies on thiolactone-class of potent anti-malarials: identification of essential structural features modulating anti-malarial activity.
    Roy KK; Bhunia SS; Saxena AK
    Chem Biol Drug Des; 2011 Sep; 78(3):483-93. PubMed ID: 21672165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural requirements of 3-carboxyl-4(1H)-quinolones as potential antimalarials from 2D and 3D QSAR analysis.
    Li J; Li S; Bai C; Liu H; Gramatica P
    J Mol Graph Model; 2013 Jul; 44():266-77. PubMed ID: 23911994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple e-pharmacophore modelling pooled with high-throughput virtual screening, docking and molecular dynamics simulations to discover potential inhibitors of Plasmodium falciparum lactate dehydrogenase (PfLDH).
    Saxena S; Durgam L; Guruprasad L
    J Biomol Struct Dyn; 2019 Apr; 37(7):1783-1799. PubMed ID: 29718775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative molecular field analysis and molecular docking studies on novel aryl chalcone derivatives against an important drug target cysteine protease in Plasmodium falciparum.
    Thillainayagam M; Anbarasu A; Ramaiah S
    J Theor Biol; 2016 Aug; 403():110-128. PubMed ID: 27185536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico analysis reveals the anti-malarial potential of quinolinyl chalcone derivatives.
    Thillainayagam M; Pandian L; Murugan KK; Vijayaparthasarathi V; Sundaramoorthy S; Anbarasu A; Ramaiah S
    J Biomol Struct Dyn; 2015; 33(5):961-77. PubMed ID: 24871811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification SAR modeling of diverse quinolone compounds for antimalarial potency against Plasmodium falciparum.
    Aher RB; Roy K
    Comb Chem High Throughput Screen; 2014; 17(5):396-406. PubMed ID: 24372050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New quinoline-5,8-dione and hydroxynaphthoquinone derivatives inhibit a chloroquine resistant Plasmodium falciparum strain.
    Hussain H; Specht S; Sarite SR; Hoerauf A; Krohn K
    Eur J Med Chem; 2012 Aug; 54():936-42. PubMed ID: 22781704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular docking and QSAR analyses for understanding the antimalarial activity of some 7-substituted-4-aminoquinoline derivatives.
    Shibi IG; Aswathy L; Jisha RS; Masand VH; Divyachandran A; Gajbhiye JM
    Eur J Pharm Sci; 2015 Sep; 77():9-23. PubMed ID: 26006759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QSAR, docking and ADMET studies of artemisinin derivatives for antimalarial activity targeting plasmepsin II, a hemoglobin-degrading enzyme from P. falciparum.
    Qidwai T; Yadav DK; Khan F; Dhawan S; Bhakuni RS
    Curr Pharm Des; 2012; 18(37):6133-54. PubMed ID: 22670592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple-layered QSAR studies on substituted 1,2,4-trioxanes as potential antimalarial agents: superiority of the quantitative pharmacophore-based alignment over common substructure-based alignment.
    Gupta AK; Saxena AK
    SAR QSAR Environ Res; 2013; 24(2):119-34. PubMed ID: 23194465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D QSAR studies on antimalarial alkoxylated and hydroxylated chalcones by CoMFA and CoMSIA.
    Xue CX; Cui SY; Liu MC; Hu ZD; Fan BT
    Eur J Med Chem; 2004 Sep; 39(9):745-53. PubMed ID: 15337287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of docking-based 3D QSAR models for the design of substituted quinoline derivatives as human dihydroorotate dehydrogenase (hDHODH) inhibitors.
    Vyas VK; Ghate M
    SAR QSAR Environ Res; 2013 Aug; 24(8):625-45. PubMed ID: 23714018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D-QSAR analysis of cycloguanil derivatives as inhibitors of A16V + S108T mutant Plasmodium falciparum dihydrofolate reductase enzyme.
    Adane L; Bharatam PV
    J Mol Graph Model; 2009 Nov; 28(4):357-67. PubMed ID: 19796975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docking studies on the binding of quinoline derivatives and hematin to Plasmodium falciparum lactate dehydrogenase.
    Cortopassi WA; Oliveira AA; Guimarães AP; Rennó MN; Krettli AU; França TC
    J Biomol Struct Dyn; 2011 Aug; 29(1):207-18. PubMed ID: 21696234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.